Price $158.42 |
Market Cap
74.07B
|
Sector Health Care |
Div. Growth
18.40%
|
|
P/E
33.0
|
P/B
14.71
|
P/S
8.92
|
Dividend %
0.90%
|
|
P/CF
-
|
P/FCF
91.7
|
Op. Cash Flow
2.2M
|
FCF
1.7
|
|
Op. Margin
34.40%
|
Net Margin
27.20%
|
ROE
49.00%
|
ROI
17.20%
|
|
ROA
16.10%
|
EPS Growth
12.20%
|
Current Ratio
2.4
|
Debt/Equity
148.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myomo Inc (MYO) | $3.43 | - | - | 35.8M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.50 | - | - | 4.1M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.90 | - | - | 14.8M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.23 | - | - | 1.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
